Search Results - "Tanner, Matthew K."
-
1
Actinomycin D Specifically Reduces Expanded CUG Repeat RNA in Myotonic Dystrophy Models
Published in Cell reports (Cambridge) (22-12-2015)“…Myotonic dystrophy type 1 (DM1) is an inherited disease characterized by the inability to relax contracted muscles. Affected individuals carry large CTG…”
Get full text
Journal Article -
2
Targeted splice sequencing reveals RNA toxicity and therapeutic response in myotonic dystrophy
Published in Nucleic acids research (26-02-2021)“…Abstract Biomarker-driven trials hold promise for therapeutic development in chronic diseases, such as muscular dystrophy. Myotonic dystrophy type 1 (DM1)…”
Get full text
Journal Article -
3
Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial
Published in Lancet neurology (01-03-2023)“…Myotonic dystrophy type 1 results from an RNA gain-of-function mutation, in which DM1 protein kinase (DMPK) transcripts carrying expanded trinucleotide repeats…”
Get full text
Journal Article -
4
Cumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patients
Published in Blood advances (10-09-2024)“…•In severe HLA-alloimmune platelet transfusion refractoriness, DSA-MFI sums >10 000 and major-ABO mismatch actionably predict poor 2-hour CCI.•Computer-aided…”
Get full text
Journal Article -
5
RNA Splicing Is a Marker of Molecular Pathology and Disease Severity in Myotonic Muscular Dystrophy
Published 01-01-2020“…Myotonic muscular dystrophy is a progressive, dominantly inherited disease characterized by skeletal muscle myotonia, weakness, and atrophy in addition to…”
Get full text
Dissertation